GBLP / Global Pharmatech, Inc. - SEC申報文件，年度報告，委任書

FORM 15 OF GLOBAL PHARMATECH, INC.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(G) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 333-67884 Global Pharmatech, Inc. (Exact name of registrant as specified in i

EX-10.1

Exhibit 10.1 EQUITY AND CLAIM TRANSFER AGREEMENT Party A: Jilin Tian Yao Science and Technology Limited Company Legal Representative: Ms. Lianqin Qu Party B: Jilin Henghe Weikang Pharmaceuticals Limited Legal Representative: Mr. Ligeng Shi Party A and Party B has made the following agreement on the transfer of Jilin Huangzhihua Pharmaceuticals Limited (formerly Jilin Yicaotang Pharmaceutical Co.,

CURRENT REPORT DATED 8-16-08

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 16, 2008 Global Pharmatech, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 333-67884 33-0976805 (State or Other Jurisdiction (Commission (IRS Employer of Inco

QTRLY REPORT FOR THE QTR ENDED 6-30-08

10-Q 1 g2529.txt QTRLY REPORT FOR THE QTR ENDED 6-30-08 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended June 30, 2008 [ ] Transition Report pursuant to 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commis

QTRLY REPORT FOR THE QTR ENDED 3-31-08

10-Q 1 g2367.txt QTRLY REPORT FOR THE QTR ENDED 3-31-08 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended March 31, 2008 [ ] Transition Report pursuant to 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commi

ANNUAL REPORT FOR THE YEAR ENDED 12-31-07

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-KSB (MARK ONE) [X] ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the annual period ended December 31, 2007 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 333-67884 GLOBAL PHARMATECH, IN

12B-25 OF GLOBAL PHARMATECH, INC.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING Commission File Number: 000-50550 CUSIP Number: 05276J-20-3 - - (Check One): [X] Form 10-K and Form 10-KSB [ ] Form 10-Q and Form 10-QSB [ ] Form 20-F [ ] Form 11-K [ ] Form N-SAR For Period Ended: December 31, 2007 - [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F

EX-99.1

Exhibit 99.1 Tom Du, MD, Ph.D. Pissaro Drive North Potomac, MD 20878 2008-2-23 February 23, 2008 Ms. Lianqin Qu Mr. Zhenyou Zhang Board of Directors Global Pharmatech, Inc Dear Ms. Qu and Mr. Zhang, Due to my busy working and travel schedules, I decided to resign from all of my positions in your company. I will no longer work for Global Pharmatech as its board member and its Chief Scientific Offic

CURRENT REPORT DATED 2-23-08

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 23, 2008 GLOBAL PHARMATECH, INC. (Exact name of registrant as specified in charter) Delaware (State or other jurisdiction of incorporation) 333-52721 33-0976805 (Commission F

LETTER

Mail Stop 6010 Via Facsimile and U.S. Mail January 4, 2008 Ms. Lianqin Qu Chief Executive Officer Global Pharmatech, Inc. 89 Ravine Edge Drive Richmond Hill, Ontario, Canada L4E 4J6 RE: Global Pharmatech, Inc. Form 10-QSB for June 30, 2007 File No. 333-67884 Dear Ms. Qu: We have completed our review of your Form 10-QSB and have no further comments at this time. Sincerely, Jim B. Rosenberg Senior A

CORRESP

[GLOBAL PHARMATECH, INC. LOGO] Global Pharmatech, Inc. 509 Maoxiang Street High-Tech Development Area Changchun, Jilin 130012 China Tel: +86 431 85541826 Fax: +86 431 85541869 Web: www.global-pharmatech.com - - Jim B. Rosenberg Senior Assistant Chief Accountant Securities and Exchange Commission Washington, D.C. 20549 November 30, 2007 RE: Global Pharmatech, Inc. Form 10-QSB for June 30. File No.

LETTER

Mail Stop 6010 Via Facsimile and U.S. Mail November 21, 2007 Ms. Lianqin Qu Chief Executive Officer Global Pharmatech, Inc. 89 Ravine Edge Drive Richmond Hill, Ontario, Canada L4E 4J6 RE: Global Pharmatech, Inc. Form 10-QSB for June 30, 2007 File No. 333-67884 Dear Ms. Qu: We have reviewed your amended filing and your response dated November 19, 2007 and have the following comments. Where indicate

AMENDMENT NO. 1 TO FORM 10-QSB

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB/A Amendment No. 1 [X] Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended June 30, 2007 [ ] Transition Report pursuant to 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period to Commission File Number 333-52721 GLOBAL PHARMAT

CORRESP

[GLOBAL PHARMATECH, INC. LOGO] GLOBAL PHARMATECH, INC. 89 Ravine Edge Drive Richmond Hill, ON L4E 4J6 Canada Tel: (905)787-8225 Fax: (905)787-9711 Web: www.global-pharmatech.com - - Jim B. Rosenberg Senior Assistant Chief Accountant Securities and Exchange Commission Washington, D.C. 20549 November 19, 2007 RE: GLOBAL PHARMATECH, INC. FORM 10-QSB FOR JUNE 30, 2007. FILE NO. 333-67884 Dear. Mr. Ros

QRTLY REPORT FOR THE QTR ENDED 9-30-07

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB [X] Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended September 30, 2007 [ ] Transition Report pursuant to 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period to Commission File Number 333-52721 GLOBAL PHARMATECH, INC. (Ex

LETTER

Mail Stop 6010 Via Facsimile and U.S. Mail October 26, 2007 Ms. Lianqin Qu Chief Executive Officer Global Pharmatech, Inc. 89 Ravine Edge Drive Richmond Hill, Ontario, Canada L4E 4J6 RE: Global Pharmatech, Inc. Form 10-QSB for June 30, 2007 File No. 333-67884 Dear Ms. Qu: We have reviewed your filing and have the following comments. We have limited our review to your financial statements and relat

QRTLY REPORT FOR THE QTR ENDED 6-30-07

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB [X] Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended June 30, 2007 [ ] Transition Report pursuant to 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period to Commission File Number 333-52721 GLOBAL PHARMATECH, INC. (Exact n

QUARTERLY REPORT FOR THE QTR ENDED 3-31-07

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB [X] Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended March 31, 2007 [ ] Transition Report pursuant to 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File Number 333-52721 GLOBAL PHARMATECH, INC. (E

EX-10.10

Exhibit 10.10 JILIN YICAOTANG PHARMACEUTICAL CO., LTD. EQUITY AND CLAIM TRANSFER AGREEMENT Party A (Transferor): Jilin Tian Yao Science and Technology Limited Company Legal Representative: Ms. Lianqin Qu Business Address: 509 Maoxiang Street, High-Tech Development Area, Changchun, Jilin, China. Party B (Transferee): Mr. Daojun Wang National ID: 220225196010230114 Where as: 1. Party A is a corporat

CURRENT REPORT DATED 5-11-07

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 - FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 May 11, 2007 Date of report (Date of earliest event reported) GLOBAL PHARMATECH, INC. (Exact Name of Registrant as Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 33-0976805 33-0976805 (Commission File

EX-10.11

Exhibit 10.11 STOCK PLEDGE AGREEMENT Pledger: Mr. Daojun Wang Pledgee: Jilin Tian Yao Science and Technology Limited Company Where as Pledger and Pledgee have entered an Equity and Claim Transfer Agreement on May 11, 2007, in the agreement, Pledger agrees to pledge 95% of the outstanding shares of Jilin Yicaotang Pharmaceutical Co., Ltd. ("YCT") after the shares are transferred to Pledger, to ensu

12B-25 OF GLOBAL PHARMATECH, INC.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING Commission File Number: 000 50550 - (Check One): [ ] Form 10-K and Form 10-KSB [X] Form 10-Q and Form 10-QSB [ ] Form 20-F [ ] Form 11-K [ ] Form N-SAR For Period Ended: March 31, 2007 - [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 1

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

================================================================================ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

EX-99.1

Exhibit 99.1 Ladies and Gentlemen: I previously orally informed Chairwoman Madam Qu on Monday April 23, 2007 of my intention to resign as Chief Financial Officer. On April 25, 2007, I further confirmed in an email of my intention to resign as both Chief Financial Officer and Director. Madam Qu asked that I allow a short time to find a replacement Chief Financial Officer, if feasible. Accordingly,

EX-10.9

Exhibit 10.9 Dated 28th day of April, 2007 Chief Financial Officer Service Contract between Global Pharmatech, Inc. and Zongsheng Zhang This Contract was made between the following two parties on 28th day of April, 2007: (1) Global Pharmatech, Inc., duly incorporated under the laws of the State of Delaware ("Party A"); and (2) Zongsheng Zhang, ("Party B"). Both parties have entered into the follow

CURRENT REPORT DATED 4-28-07

================================================================================ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

ANNUAL REPORT FOR THE YEAR ENDED 12-31-06

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-KSB (MARK ONE) [X] ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the annual period ended December 31, 2006 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 333-67884 GLOBAL PHARMATECH, IN

12B-25 OF GLOBAL PHARMATECH, INC.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING Commission File Number: 000 50550 - (Check One): [X] Form 10-K and Form 10-KSB [ ] Form 10-Q and Form 10-QSB [ ] Form 20-F [ ] Form 11-K [ ] Form N-SAR For Period Ended: December 31, 2006 - [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on For

FORM S-8 OF GLOBAL PHARMATECH, INC.

As filed with the Securities and Exchange Commission on January 12, 2007 Registration No.

FORM SB-2 OF GLOBAL PHARMATECH, INC.

As filed with the Securities and Exchange Commission on January 12, 2007 Registration No.

DEFINITIVE N&PS OF GLOBAL PHARMATECH, INC.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant [X] Filed by a Party other than the Registrant [ ] Check the appropriate box: [ ] Preliminary Proxy Statement [ ] Confidential, For Use of the [X] Definitive Proxy Statement Commission Only (as permitted [ ] De

CURRENT REPORT DATED 12-1-06

================================================================================ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

QUARTERLY REPORT FOR THE QTR ENDED 9-30-06

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB [X] Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended September 30, 2006 [ ] Transition Report pursuant to 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period to Commission File Number 333-52721 GLOBAL PHARMATECH, INC. (Ex

Current Report

================================================================================ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

EX-10.1

Exhibit 10.1 Dated 9th day of October, 2006 Form of Director Service Contract between Global Pharmatech, Inc. and Zhenyou Zhang [Chinese Translation] This Contract was made between the following two parties on 9th October, 2006: [Chinese Translation] (1) Global Pharmatech, Inc., duly incorporated under the laws of the State of Delaware ("Party A"); and[Chinese Translation] (2) Zhenyou Zhang, ("Par

EX-10.2

Exhibit 10.2 Dated 9th day of October, 2006 Director and Chief Financial Officer Service Contract between Global Pharmatech, Inc. and Joseph Levinson [Chinese Translation] This Contract was made between the following two parties on 9th of October, 2006: [Chinese Translation] (1) Global Pharmatech, Inc., duly incorporated under the laws of the State of Delaware ("Party A"); and [Chinese Translation

QUARTERLY REPORT FOR THE QTR ENDED 6/30/06

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB [X] Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended June 30, 2006 [ ] Transition Report pursuant to 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period to Commission File Number 333-52721 GLOBAL PHARMATECH, INC. (Exact n

12B-25 OF GLOBAL PHARMATECH, INC.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING Commission File Number: 001 57300 - (Check One): [ ] Form 10-K and Form 10-KSB [X] Form 10-Q and Form 10-QSB [ ] Form 20-F [ ] Form 11-K [ ] Form N-SAR For Period Ended: June 30, 2006 - [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11

SCHEDULE 13D OF ZHENYOU ZHANG

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* Global Pharamatech, Inc. (Name of Issuer) Common Stock, par value $.0001 per share (Title of Class of Securities) 05276J-20-3 (CUSIP Number) Mitchell S. Nussbaum, Esq., Loeb & Loeb LLP, 345 Park Avenue, New York, NY 10154 (Name, Address and Telephone Numb

QUARTERLY REPORT FOR THE QTR ENDED 3/31/06

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB [X] Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended March 31, 2006 [ ] Transition Report pursuant to 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File Number 333-52721 GLOBAL PHARMATECH, INC. (E

CURRENT REPORT DATED 4/28/06

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 - FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report: April 28, 2006 (Date of earliest event reported) - GLOBAL PHARMATECH, INC. (Exact name of registrant as specified in charter) Delaware (State or other Jurisdiction of Incorporation or Organization) 33-0976805 33-097

EX-10.1

EXHIBIT 10.1 SUBSCRIPTION AGREEMENT FOR REGULATION S INVESTORS This Subscription Agreement (the "Agreement") dated as of April 27, 2006, has been executed by the undersigned (the "Subscriber") in connection with a private offer and sale (the "Offering") of shares (the "Shares") of common stock, $.0001 par value per share (the "Common Stock"), of Global Pharmatech, Inc., a Delaware corporation (the

ANNUAL REPORT FOR THE YEAR ENDED 12/31/05

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 - FORM 10-KSB (MARK ONE) [X] ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the annual period ended December 31, 2005 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to COMMISSION FILE NO. 333-67884 GLOBAL PHARMATECH, INC.

PROSPECTUS Global Pharmatech, Inc. 3,247,308 Shares of Common Stock

Filed pursuant to Rule 424(b)(3) Registration No. 333-131039 THE INFORMATION IN THIS PROSPECTUS IS NOT COMPLETE AND MAY BE CHANGED. THE SELLING STOCKHOLDERS MAY NOT SELL THESE SECURITIES PUBLICLY UNTIL THE REGISTRATION STATEMENT FILED WITH THE SECURITIES AND EXCHANGE COMMISSION IS EFFECTIVE. THIS PROSPECTUS IS NOT AN OFFER TO SELL THESE SECURITIES AND IT IS NOT SOLICITING AN OFFER TO BUY THESE SEC

As filed with the Securities and Exchange Commission on February 10, 2006

As filed with the Securities and Exchange Commission on February 10, 2006 Registration No.

SUBSIDIARIES OF THE REGISTRANT

EX-21 2 v033225ex21.htm EXHIBIT 21 SUBSIDIARIES OF THE REGISTRANT Name Place of Organization Trade Names Used Natural Pharmatech, Inc. (wholly owned by registrant) British Virgin Islands Global Health System, Inc. (wholly owned by registrant) New York Natural Pharmatech (Jilin China) Co., Ltd. (wholly owned by Natural Pharmatech) People’s Republic of China Jilin Ben Cao Tang Pharmacy Co., Ltd. (75

As filed with the Securities and Exchange Commission on January 13, 2006

As filed with the Securities and Exchange Commission on January 13, 2006 Registration No.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) December 30, 2005 GLOBAL PHARMATECH, INC. (Exact Name of Registrant as Specified in Charter) Delaware (State or Other Jurisdiction of Incorporation) 33-0976805 (Commission File Number)

Chief Financial Officer Service Contract Global Pharmatech, Inc. Joseph Levinson

Exhibit 10.1 Dated 1st day of January, 2006 Chief Financial Officer Service Contract between Global Pharmatech, Inc. and Joseph Levinson This Contract was made between the following two parties on 1 January, 2006: (1) Global Pharmatech, Inc., duly incorporated under the laws of the State of Delaware ("Party A"); and (2) Joseph Levinson, ("Party B"). Both parties have entered into the following agr

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB x Quarterly Report under Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended September 30, 2005 ¨ Transition Report under Section 13 or 15(d) of the Exchange Act For the transition period from to Commission File Number 333-52721 GLOBAL PHARMATECH, INC. (Exact name of small busi

10QSB

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB |X| Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended June 30, 2005 || Transition Report pursuant to 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period to Commission File Number 333-52721 - GLOBAL PHARMATECH, INC. (Exact

EX-10.1

v025565ex10-1 - Converted by SECPublisher 2.1.1.8, created by BCL Technologies Inc., for SEC Filing

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 - FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report: August 18, 2005 (Date of earliest event reported) - GLOBAL PHARMATECH, INC. (Exact name of registrant as specified in charter) Delaware (State or other Jurisdiction of Incorporation or Organization) 33-0976805 33-09

10QSB

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB |X| Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended March 31, 2005 || Transition Report pursuant to 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period to Commission File Number 333-52721 - GLOBAL PHARMATECH, INC. (Exact

EX-10.1

Dated 20th day of June, 2005 Executive Employment Contract between Global Pharmatech, Inc.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 - FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report: June 20, 2005 (Date of earliest event reported) - GLOBAL PHARMATECH, INC. (Exact name of registrant as specified in charter) Delaware (State or other Jurisdiction of Incorporation or Organization) 33-0976805 33-0976

12B-25 OF GLOBAL PHARMATECH, INC.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING Commission File Number: 001 57300 - (Check One): [ ] Form 10-K and Form 10-KSB [X] Form 10-Q and Form 10-QSB [ ] Form 20-F [ ] Form 11-K [ ] Form N-SAR For Period Ended: June 30, 2005 - [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11

12B-25 OF GLOBAL PHARMATECH, INC.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING Commission File Number: 001 57300 - (Check One): [ ] Form 10-K and Form 10-KSB [X] Form 10-Q and Form 10-QSB [ ] Form 20-F [ ] Form 11-K [ ] Form N-SAR For Period Ended: March 31, 2005 - [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 1

CURRENT REPORT DATED 5-13-05

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 - FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report: (Date of earliest event reported) May 13, 2005 GLOBAL PHARMATECH, INC. (Exact name of registrant as specified in charter) Delaware (State or other Jurisdiction of Incorporation or Organization) 33-0976805 33-0976805

EX-99.1

Exhibit 99.1 NATURAL PHARMATECH, INC. AND SUBSIDIARIES CONSOLIDATED FINANCIAL STATEMENTS DECEMBER 31, 2004 NATURAL PHARMATECH, INC. AND SUBSIDIARIES Report of Independent Registered Public Accounting Firm 1 Consolidated Balance Sheet as of December 31, 2004 2 Consolidated Statements of Operations for the years ended December 31, 2004 and 2003 3 Consolidated Statements of Stockholders' Equity for t

AMENDMENT NO. 1 TO FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 - FORM 8-K/A CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report: (Date of earliest event reported) February 9, 2005 - GLOBAL PHARMATECH, INC. (Exact name of registrant as specified in charter) Delaware (State or other Jurisdiction of Incorporation or Organization) 33-0976805 33

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 - FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report: (Date of earliest event reported) April 20, 2005 - GLOBAL PHARMATECH, INC. (Exact name of registrant as specified in charter) Delaware (State or other Jurisdiction of Incorporation or Organization) 33-0976805 33-097

EX-16.1

EXHIBIT 16.1 April 25, 2005 Securities and Exchange Commission Washington, D.C. 20549 Ladies and Gentlemen: I was previously principal accountant for Global Pharmatech, Inc. (f/k/a Autocarbon., Inc., the "Company") and I reviewed the Company's consolidated financial statements as of June 30, September 30 and December 31, 2004 and for the interim periods ended June 30, September 30 and December 31,

S-8

As filed with the Securities and Exchange Commission on March 14, 2005 Registration No.

EX-4.1

Exhibit 4.1 COMPENSATION AGREEMENT THIS COMPENSATION AGREEMENT (this Agreement") is made as of the 14 day of March, 2005 by and between Global Pharmatech, Inc., a Delaware corporation ("the Company"), and Simon Thurlow, an individual residing at Suite 3B, 126 East 83rd Street, New York, New York 10028 (the "Consultant"). WHEREAS, the Company is a publicly traded company whose shares are quoted on

10QSB/A

================================================================================ UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 - FORM 10-QSB/A - |X| QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2004 OR || TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO 005-78248 (Commission file number) GLOBAL PHARMATECH, INC.

10QSB/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-QSB/A |X| QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2004 OR || TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO 005-78248 (Commission file number) GLOBAL PHARMATECH, INC.

10QSB

================================================================================ UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 - FORM 10-QSB - |X| QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED DECEMBER 31, 2004 OR || TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO 005-78248 (Commission file number) GLOBAL PHARMATECH, INC.

Changes in Registrant's Certifying Accountant

8-K 1 v0136408k.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): FEBRUARY 11, 2005 GLOBAL PHARMATECH, INC. (Exact name of registrant as specified in its charter) Delaware 005-78248 33-0976805 - - - (State or other jurisdiction (

EX-16.1

EX-16.1 2 v013640ex16-1.txt February 11, 2005 Securities and Exchange Commission Washington, D.C. 20549 Ladies and Gentlemen: I have resigned as principal accountant for Global Pharmatech, Inc. I have read Global Pharmatech, Inc.'s statements included under Item 4.01 of its Form 8-K dated February 28, 2005, and I agree with such statements, except that I am not in a position to agree or disagree w

EX-10.3

Dated 8th day of February, 2005 Form of Executive Services Contract between Global Pharmatech, Inc.

EX-10.5

Dated 8th day of February, 2005 Form of Executive Employment Contract between Global Pharmatech, Inc.

EX-10.6

Dated 14th day of February, 2005 Form of Director and Chief Technology Officer Service Contract between Global Pharmatech, Inc.

EX-10.4

Dated 8th day of February, 2005 Form of Executive Employment Contract between Global Pharmatech, Inc.

8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): FEBRUARY 9, 2005 GLOBAL PHARMATECH, INC. (Exact name of registrant as specified in its charter) Delaware 005-78248 33-0976805 - - - - (State or other jurisdiction (Commission File Num

EX-10.2

Exhibit 10.2 Dated 8th day of February, 2005 Form of Executive Employment Contract between Global Pharmatech, Inc. and Xiaobo Sun This Contract was made between the following two parties on 8th February, 2005: (1) Global Pharmatech, Inc., duly incorporated under the laws of the State of Delaware ("Party A"); and (2) Xiaobo Sun, ("Party B"). Both parties have entered into the following agreement th

NT 10-Q

Microsoft Word 10.0.2627; UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): [ ] Form 10-KSB [ ] Form 20-F [ ]Form 11-K [X]Form 10-QSB [ ] Form N-SAR [ ] Form N-CSR For Period Ended: December 31, 2004 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transition Repor

EX-4.1

CERTIFICATE OF AMENDMENT TO THE CERTIFICATE OF INCORPORATION OF AUTOCARBON, INC. The undersigned, being the President and Chief Financial Officer of AUTOCARBON, INC., a corporation existing under the laws of the State of Delaware, does hereby certify as follows: 1. The name of the Corporation is Autocarbon, Inc. (the "Corporation"). The date of filing the original certificate of incorporation with

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): JANUARY 31, 2005 GLOBAL PHARMATECH, INC. (Exact name of registrant as specified in its charter) Delaware 333-67884 33-0976805 - - - (State or other jurisdiction (Commission File Numbe

8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): JANUARY 24, 2005 AUTOCARBON, INC. - (Exact name of registrant as specified in its charter) Delaware 005-78248 33-0976805 - - - - (State or other jurisdiction (Commission (IRS Employer

EX-4.1

THIS AGREEMENT RELATES TO AN OFFERING OF SECURITIES IN AN OFFSHORE TRANSACTION TO PERSONS WHO ARE NOT U.

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): DECEMBER 28, 2004 AUTOCARBON, INC. - (Exact name of registrant as specified in its charter) Delaware 005-78248 33-0976805 - - - - (State or other jurisdiction (Commission File Number)

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): DECEMBER 23, 2004 AUTOCARBON, INC. (Exact name of registrant as specified in its charter) Delaware 005-78248 33-0976805 - - - (State or other jurisdiction (Commission File Number) (IR

EX-10.1

COMMON STOCK PURCHASE AGREEMENT THIS COMMON STOCK PURCHASE AGREEMENT is entered into as of this 23rd day of December, 2004 (this "Agreement"), by and between the seller listed on Schedule 1.

LETTER

December 26, 2004 Mail Stop 0305 Via U.S. Mail Simon Thurlow, President AutoCarbon, Inc. 126 E. 83rd Street, Suite 2F New York, NY 10028 Re: Form 8-K filed December 16, 2004 File No.: 333-67884 Dear Mr. Thurlow: We have reviewed your filing and have the following comments. Where indicated, we think you should revise your document in response to this comment. Please understand that the purpose of o

8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of Report (Date of earliest reported): September 28, 2004 AUTOCARBON, INC.

EX-16

September 28, 2004 Securities and Exchange Commission Washington, D.C. 20549 Ladies and Gentlemen: I was previously principal accountant for Autocarbon, Inc. and, under the date of May 18, 2004, I reported on the consolidated financial statements of Autocarbon, Inc. as of March 31, 2004 and for the years ended March 31, 2004 and on the financial statements end March 31, 2003. On today, we resigned

10QSB

================================================================================ UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 - FORM 10-QSB - |X| QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2004 OR || TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO 005-78248 (Commission file number) AUTOCARBON, INC.

S-8

S-8 FORM S-8 FOR COMPENSATION SHARES FOR SIMON THURLOW As filed with the Securities and Exchange Commission on October 20, 2004 Registration No.

EX-4

EX-4 COMPENSATION AGREEMENT BETWEEN AUTOCARBON AND SIMON THURLOW COMPENSATION AGREEMENT THIS COMPENSATION AGREEMENT (this Agreement") is made as of the 29th day of September, 2004 by and between Autocarbon, Inc.

10QSB

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-QSB |X| QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2004 OR || TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO 005-78248 (Commission file number) AUTOCARBON, INC.

10KSB

UNITED STATES SECURITIES AND EXCHANGE COMMISSSION WASHINGTON, D.C. 20549 FORM 10-KSB |X| ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934: For the fiscal year ending March 31, 2004 || TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934: For the transition period from to Commission file number: 005-78248 AUTOCARBON, INC. - (Name of small

EX-2.1

Exhibit 2.1 STOCK PURCHASE AGREEMENT AND PLAN OF REORGANIZATION THIS STOCK PURHCASE AGREEMENT AND PLAN OF REORGANIZATION (the "Agreement") is made this 27th day of January 2004, by and among Autocarbon, Inc., a Delaware corporation ("ATCB"); New Concepts Nutraceuticals, Inc., a Delaware corporation ("NCN"); and the persons listed in Exhibit A-1 hereof who are the owners of record of all the issued

8-K/A

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Event Requiring Report: February 15, 2004 AUTOCARBON, INC. - - (Exact name of registrant as specified in its charter) Delaware 005-78248 33-0976805 (State of Incorporation) (Commission File Number) (IRS Employer Identification #) 126 East

Current Report

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Event Requiring Report: February 15, 2004 AUTOCARBON, INC. (Exact name of registrant as specified in its charter) Delaware 005-78248 33-0976805 (State of Incorporation) (Commission File Number) (IRS Employer Identification #) 126 East 83rd

NT 10-K

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 Commission File Number 005-78248 NOTIFICATION OF LATE FILING (Check One): [X] Form 10-K [ ] Form 11-K [ ] Form 20-F [ ] Form 10-Q [ ] Form N-SAR For Period Ended: March 31, 2004 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transition Report on Form 10-Q [ ] Transiti

10KSB/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSSION WASHINGTON, D.C. 20549 FORM 10-KSB/A |X| ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934: For the fiscal year ending March 31, 2003 || TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934: For the transition period from to Commission file number: 005-78248 AUTOCARBON, INC. - (Name of smal

8-K/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K/A CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of Report (Date of earliest reported): October 16, 2003 AUTOCARBON, INC.

10QSB

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB Quarterly Report Pursuant to Section 13 or 15(D) of The Securities Act of 1934 For the quarterly period ended: June 30, 2003 Commission file number: 005-78248 AUTOCARBON, INC. (Exact name of small business issuer as specified in its charter) Delaware 33-0976805 (State or other jurisdiction of (IRS Employee Identifi

10QSB

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB Quarterly Report Pursuant to Section 13 or 15(D) of The Securities Act of 1934 For the quarterly period ended: September 30, 2003 Commission file number: 005-78248 AUTOCARBON, INC. (Exact name of small business issuer as specified in its charter) Delaware 33-0976805 (State or other jurisdiction of (IRS Employee Ide

10QSB

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB Quarterly Report Pursuant to Section 13 or 15(D) of The Securities Act of 1934 For the quarterly period ended: December 31, 2003 Commission file number: 005-78248 AUTOCARBON, INC. (Exact name of small business issuer as specified in its charter) Delaware 33-0976805 (State or other jurisdiction of (IRS Employee Iden

10KSB

UNITED STATES SECURITIES AND EXCHANGE COMMISSSION WASHINGTON, D.C. 20549 FORM 10-KSB |X| ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934: For the fiscal year ending September 30, 2003 || TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934: For the transition period from to Commission file number: 005-78248 AUTOCARBON, INC. - (Name of sm

NT 10-K

SEACURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 Commission File Number: 0-24962 NOTIFICATION OF LATE FILING |X| Form 10-K || Form 11-K || Form 20-F ||Form 10-Q || Form N-SAR For Year Ended: March 31, 2003 || Transition Report on Form 10-K || Transition Report on Form 10-Q || Transition Report on Form 20-F || Transition Report on Form N-SAR For the Transition Period Ended: No

EX-4

Exhibit 4.25 AMENDED COMPENSATION AGREEMENT This Amended Compensation Agreement is dated as of June 16, 2003 among Autocarbon, Inc., a Delaware corporation (the "Company") and Ronald Murphy ("Consultant"). WHEREAS, the Company had requested that the Consultant provide the Company with services in connection with their business, and the Consultants provided the Company with such services; WHEREAS,

EX-4

Exhibit 4.26 AMENDED COMPENSATION AGREEMENT This Amended Compensation Agreement is dated as of June 16, 2003 among Autocarbon, Inc., a Delaware corporation (the "Company") and Graham Butler ("Consultant"). WHEREAS, the Company had requested that the Consultant provide the Company with services in connection with their business, and the Consultants provided the Company with such services; WHEREAS,

S-8 POS

As filed with the Securities and Exchange Commission on June 17, 2003 Registration No.

EX-4

Exhibit 4.21 COMPENSATION AGREEMENT This Compensation Agreement is dated as of April 28, 2003 among Autocarbon, Inc., a Delaware corporation (the "Company") and Rennell Trading ("Consultant"). WHEREAS, the Company had requested that the Consultant provide the Company with services in connection with their business, and the Consultants provided the Company with such services; and WHEREAS, the Compa

EX-4

Exhibit 4.12 COMPENSATION AGREEMENT This Compensation Agreement is dated as of April 28, 2003 among Autocarbon, Inc., a Delaware corporation (the "Company") and Robert Miller ("Consultant"). WHEREAS, the Company had requested that the Consultant provide the Company with services in connection with their business, and the Consultants provided the Company with such services; and WHEREAS, the Company

EX-4

EX-4 27 aprils8ex424.txt Exhibit 4.24 COMPENSATION AGREEMENT This Compensation Agreement is dated as of February 20, 2003 among Autocarbon, Inc., a Delaware corporation (the "Company") and Noelle Tutunjian ("Consultant"). WHEREAS, the Consultant has provided and will provide EDGAR services for the Company; and WHEREAS, the Company wishes to compensate the Consultant with shares of its common stock

EX-4

EX-4 17 aprils8ex410.txt Exhibit 4.10 COMPENSATION AGREEMENT This Compensation Agreement is dated as of April 28, 2003 among Autocarbon, Inc., a Delaware corporation (the "Company") and Teo Montoya ("Consultant"). WHEREAS, the Company had requested that the Consultant provide the Company with services in connection with their business, and the Consultants provided the Company with such services; a

EX-4

Exhibit 4.16 COMPENSATION AGREEMENT This Compensation Agreement is dated as of April 28, 2003 among Autocarbon, Inc., a Delaware corporation (the "Company") and Julia Trow ("Consultant"). WHEREAS, the Company had requested that the Consultant provide the Company with services in connection with their business, and the Consultants provided the Company with such services; and WHEREAS, the Company co

EX-4

EX-4 16 aprils8ex411.txt Exhibit 4.11 COMPENSATION AGREEMENT This Compensation Agreement is dated as of April 28, 2003 among Autocarbon, Inc., a Delaware corporation (the "Company") and Peter Moseley ("Consultant"). WHEREAS, the Company had requested that the Consultant provide the Company with services in connection with their business, and the Consultants provided the Company with such services;

EX-4

EX-4 12 aprils8ex415.txt Exhibit 4.15 COMPENSATION AGREEMENT This Compensation Agreement is dated as of April 28, 2003 among Autocarbon, Inc., a Delaware corporation (the "Company") and Sebastian Reidl ("Consultant"). WHEREAS, the Company had requested that the Consultant provide the Company with services in connection with their business, and the Consultants provided the Company with such service

EX-4

EX-4 4 aprils8ex423.txt Exhibit 4.23 COMPENSATION AGREEMENT This Compensation Agreement is dated as of April 23, 2003 among Autocarbon, Inc., a Delaware corporation (the "Company") and Sichenzia Ross Friedman Ference LLP ("Consultants"). WHEREAS, the Company has requested the Consultants to provide the Company with legal services in connection with their business, and the Consultants have agreed t

EX-4

EX-4 10 aprils8ex417.txt Exhibit 4.17 COMPENSATION AGREEMENT This Compensation Agreement is dated as of April 28, 2003 among Autocarbon, Inc., a Delaware corporation (the "Company") and Barry and Carol Grant ("Consultant"). WHEREAS, the Company had requested that the Consultant provide the Company with services in connection with their business, and the Consultants provided the Company with such s

EX-4

EX-4 22 aprils8ex45.txt Exhibit 4.5 COMPENSATION AGREEMENT This Compensation Agreement is dated as of April 28, 2003 among Autocarbon, Inc., a Delaware corporation (the "Company") and James Boetcher ("Consultant"). WHEREAS, the Company had requested that the Consultant provide the Company with services in connection with their business, and the Consultants provided the Company with such services;

EX-4

Exhibit 4.20 COMPENSATION AGREEMENT This Compensation Agreement is dated as of April 28, 2003 among Autocarbon, Inc., a Delaware corporation (the "Company") and Peter Ayres ("Consultant"). WHEREAS, the Company had requested that the Consultant provide the Company with services in connection with their business, and the Consultants provided the Company with such services; and WHEREAS, the Company c

EX-4

EX-4 8 aprils8ex419.txt Exhibit 4.19 COMPENSATION AGREEMENT This Compensation Agreement is dated as of April 28, 2003 among Autocarbon, Inc., a Delaware corporation (the "Company") and Simon Farrell ("Consultant"). WHEREAS, the Company had requested that the Consultant provide the Company with services in connection with their business, and the Consultants provided the Company with such services;

S-8

S-8 1 aprils8.txt As filed with the Securities and Exchange Commission on April 30, 2003 Registration No. 333- - SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT Under The Securities Act of 1933 (Includes Registration of Shares for resale by means of a Form S-3 Prospectus) - AUTOCARBON, INC. (Exact name of registrant as specified in its charter) Delaware 33

EX-4

Exhibit 4.1 AUTOCARBON, INC. 2003 STOCK INCENTIVE PLAN 1. Purpose The purpose of this 2003 Stock Incentive Plan (the "Plan") of Autocarbon, Inc., a Delaware corporation (the "Company"), is to advance the interests of the Company's stockholders by enhancing the Company's ability to attract, retain and motivate persons who make (or are expected to make) important contributions to the Company by prov

EX-4

EX-4 19 aprils8ex48.txt Exhibit 4.8 COMPENSATION AGREEMENT This Compensation Agreement is dated as of April 28, 2003 among Autocarbon, Inc., a Delaware corporation (the "Company") and Hal Evans ("Consultant"). WHEREAS, the Company had requested that the Consultant provide the Company with services in connection with their business, and the Consultants provided the Company with such services; and W

EX-4

EX-4 15 aprils8ex414.txt Exhibit 4.14 COMPENSATION AGREEMENT This Compensation Agreement is dated as of April 28, 2003 among Autocarbon, Inc., a Delaware corporation (the "Company") and Dennis Potter ("Consultant"). WHEREAS, the Company had requested that the Consultant provide the Company with services in connection with their business, and the Consultants provided the Company with such services;

EX-4

EX-4 13 aprils8ex413.txt Exhibit 4.13 COMPENSATION AGREEMENT This Compensation Agreement is dated as of April 28, 2003 among Autocarbon, Inc., a Delaware corporation (the "Company") and Ronald Murphy ("Consultant"). WHEREAS, the Company had requested that the Consultant provide the Company with services in connection with their business, and the Consultants provided the Company with such services;

EX-4

EX-4 23 aprils8ex44.txt Exhibit 4.4 COMPENSATION AGREEMENT This Compensation Agreement is dated as of April 28, 2003 among Autocarbon, Inc., a Delaware corporation (the "Company") and Barry Bridge ("Consultant"). WHEREAS, the Company had requested that the Consultant provide the Company with services in connection with their business, and the Consultants provided the Company with such services; an

EX-4

Exhibit 4.2 COMPENSATION AGREEMENT This Compensation Agreement is dated as of April 28, 2003 among Autocarbon, Inc., a Delaware corporation (the "Company") and Jack Brabham ("Consultant"). WHEREAS, the Company had requested that the Consultant provide the Company with services in connection with their business, and the Consultants provided the Company with such services; and WHEREAS, the Company c

EX-4

EX-4 24 aprils8ex43.txt Exhibit 4.3 COMPENSATION AGREEMENT This Compensation Agreement is dated as of April 28, 2003 among Autocarbon, Inc., a Delaware corporation (the "Company") and Ian Burns ("Consultant"). WHEREAS, the Company had requested that the Consultant provide the Company with services in connection with their business, and the Consultants provided the Company with such services; and W

EX-4

EX-4 21 aprils8ex46.txt Exhibit 4.6 COMPENSATION AGREEMENT This Compensation Agreement is dated as of April 28, 2003 among Autocarbon, Inc., a Delaware corporation (the "Company") and Graham Butler ("Consultant"). WHEREAS, the Company had requested that the Consultant provide the Company with services in connection with their business, and the Consultants provided the Company with such services; a

EX-4

Exhibit 4.18 COMPENSATION AGREEMENT This Compensation Agreement is dated as of April 28, 2003 among Autocarbon, Inc., a Delaware corporation (the "Company") and Terry Keller ("Consultant"). WHEREAS, the Company had requested that the Consultant provide the Company with services in connection with their business, and the Consultants provided the Company with such services; and WHEREAS, the Company

EX-4

Exhibit 4.22 COMPENSATION AGREEMENT This Compensation Agreement is dated as of April 23, 2003 among Autocarbon, Inc., a Delaware corporation (the "Company") and George Riggs and Riggs & Associates LLC ("Consultants"). WHEREAS, the Company has requested the Consultants to provide the Company with certain accounting consulting services in connection with their business, and the Consultants have prov

EX-4

EX-4 20 aprils8ex47.txt Exhibit 4.7 COMPENSATION AGREEMENT This Compensation Agreement is dated as of April 28, 2003 among Autocarbon, Inc., a Delaware corporation (the "Company") and Alison Butler ("Consultant"). WHEREAS, the Company had requested that the Consultant provide the Company with services in connection with their business, and the Consultants provided the Company with such services; a

EX-4

EX-4 18 aprils8ex49.txt Exhibit 4.9 COMPENSATION AGREEMENT This Compensation Agreement is dated as of April 28, 2003 among Autocarbon, Inc., a Delaware corporation (the "Company") and James Millichap-Merrick ("Consultant"). WHEREAS, the Company had requested that the Consultant provide the Company with services in connection with their business, and the Consultants provided the Company with such s

EX-10.2

EXHIBIT 10.2 AMENDMENT NO. 1 TO THE SHARE EXCHANGE AGREEMENT AGREEMENT made as of the 20th day of February, 2003, by and between Autocarbon, Inc., a Delaware corporation with an office at 136-M Tenth Street, Ramona, California 92063 ("AutoC"), and Autocarbon Limited, a UK registered company with an office at 26 Nailsworth Mills, Nailsworth, Gloucestershire, England GL6 0BS ("Autocarbon LTD") and J

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K/A CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of Report (Date of earliest reported): April 16, 2003 AUTOCARBON, INC.

EX-99

EXHIBIT 99.2 Certification Pursuant to 18 U.S.C. Section 1350, As Adopted Pursuant to Section 906 of The Sarbanes-Oxley Act of 2002 I, Kimberly Tate, the Chief Financial Officer of Autocarbon, Inc. (the "Company"), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that to the best of my knowledge: (1) the Quarterly Report on Form 10-QSB of the Company for

10QSB

As Filed with the Securities and Exchange Commission on February 19, 2003 ================================================================================ SECURITIES AND EXCHANGE COMMISSION Washington, D.

EX-99

EXHIBIT 99.1 Certification Pursuant to 18 U.S.C. Section 1350, As Adopted Pursuant to Section 906 of The Sarbanes-Oxley Act of 2002 I, James Miller, the Chief Executive Officer of Autocarbon, Inc. (the "Company"), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that to the best of my knowledge: (1) the Quarterly Report on Form 10-QSB of the Company for t

NT 10-Q

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12B-25 Commission File Number: 0-24962 NOTIFICATION OF LATE FILING || Form 10-K || Form 11-K || Form 20-F |X| Form 10-Q || Form N-SAR For Quarter Ended: December 31, 2002 || Transition Report on Form 10-K || Transition Report on Form 10-Q || Transition Report on Form 20-F || Transition Report on Form N-SAR For the Transition Period End

8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of Report (Date of earliest reported): January 17, 2003 AUTOCARBON, INC.

EX-10.1

EXHIBIT 10.1 SHARE EXCHANGE AGREEMENT AGREEMENT made as of the 3rd day of January, 2003, by and between Autocarbon, Inc., a Delaware corporation with an office at 136-M Tenth Street, Ramona, California 92063 ("AutoC"), and Autocarbon Limited, a UK registered company with an office at 26 Nailsworth Mills, Nailsworth, Gloucestershire, England GL6 0BS ("Autocarbon LTD") and James Millichap-Merrick, G

EX-99.1

EXHIBIT 99.1 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 I, James Miller, the Chief Executive Officer of Autocarbon, Inc. (the "Company"), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that to the best of my knowledge: (1) the Quarterly Report on Form 10-QSB of the Company for t

EX-99.2

EXHIBIT 99.2 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 I, Kimberly Tate, the Chief Financial Officer of Autocarbon, Inc. (the "Company"), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that to the best of my knowledge: (1) the Quarterly Report on Form 10-QSB of the Company for

10QSB

As Filed with the Securities and Exchange Commission on November 18, 2002 ================================================================================ SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.

NT 10-Q

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 Commission File Number: 0-24962 NOTIFICATION OF LATE FILING || Form 10-K || Form 11-K || Form 20-F |X|Form 10-Q || Form N-SAR For Quarter Ended: September 30, 2002 || Transition Report on Form 10-K || Transition Report on Form 10-Q || Transition Report on Form 20-F || Transition Report on Form N-SAR For the Transition Period End

DEF 14C

SCHEDULE 14C (RULE 14C-101) Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: [ ] Preliminary Information Statement [X] Definitive Information Statement [ ] Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) AUTOCARBON.

PRE 14C

SCHEDULE 14C (RULE 14C-101) Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: [X] Preliminary Information Statement [ ] Definitive Information Statement [ ] Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) AUTOCARBON.

PRE 14C

SCHEDULE 14C (RULE 14C-101) Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: [X] Preliminary Information Statement [ ] Definitive Information Statement [ ] Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) AUTOCARBON.

EX-99.2

EXHIBIT 99.2 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 I, Kimberly Tate, the Chief Financial Officer of Autocarbon.com, Inc. (the "Company"), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that to the best of my knowledge: (1) the Quarterly Report on Form 10-QSB of the Company

10QSB

As Filed with the Securities and Exchange Commission on August 13, 2001 ================================================================================ SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.

EX-99.1

EXHIBIT 99.1 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 I, James Miller, the Chief Executive Officer of Autocarbon.com, Inc. (the "Company"), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that to the best of my knowledge: (1) the Quarterly Report on Form 10-QSB of the Company f

EX-99.2

EXHIBIT 99.2 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 I, Kimberly Tate, the Chief Financial Officer of Autocarbon.com, Inc. (the "Company"), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that to the best of my knowledge: (1) the Special Financial Report on Form 10-KSB of the

EX-99.1

EXHIBIT 99.1 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 I, James Miller, the Chief Executive Officer of Autocarbon.com, Inc. (the "Company"), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that to the best of my knowledge: (1) the Special Financial Report on Form 10-KSB of the C

10KSB

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-KSB ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended March 31, 2002 Commission File No. 005-78248 AUTOCARBON.COM, INC. (Name of Small Business Issuer in Its Charter) Delaware 33-0976805 (State or Other Jurisdiction of (I.R.S. Employer Incorporation or Organization) Identificati

JUDY GROSSMAN

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO.) Autocarbon.com, Inc. - - (Name of Issuer) Common Stock, $.0001 par value per share - - 05276J 10 4 - - (Cusip Number) March 31, 2002 - - (Date of Event Which Requires Filing of this Statement) CUSIP No. 05276J 10 4 (1) Name of Reporting Person: Judy Grossman (2) Check th

SETH SCALLY

SC 13G 1 auto13g-scally.txt SETH SCALLY SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO.) Autocarbon.com, Inc. - (Name of Issuer) Common Stock, $.0001 par value per share - 05276J 10 4 - (Cusip Number) March 31, 2002 - (Date of Event Which Requires Filing of this Statement) CUSIP No. 05276J 10 4 (1) Name of Reporting Pe

JAMES MILLER

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO.) Autocarbon.com, Inc. - - (Name of Issuer) Common Stock, $.0001 par value per share - - 05276J 10 4 - - (Cusip Number) March 31, 2002 - - (Date of Event Which Requires Filing of this Statement) CUSIP No. 05276J 10 4 (1) Name of Reporting Person: James Miller (2) Check the

POS AM

As filed with the Securities and Exchange Commission on April 26, 2002. Registration No. 333-67884 ================================================================================ SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST EFFECTIVE AMENDMENT No. 1 to FORM SB-2 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 - AUTOCARBON.COM, INC. (Name of Small Business Issuer in its C

424B3

Filed pursuant to Rule 424(b)(3) File No. 333-67884 Prospectus Supplement (To Prospectus dated April 12, 2002) AUTOCARBON.COM, INC. 3,668,400 Shares, common stock - This prospectus supplement relates to the resale by the holders of 2,309,200 shares of common stock, par value of $0.0001 of Autocarbon.com, Inc., and 1,059,200 shares of common stock, par value of $0.0001, issuable upon the exercise o

SB-2/A

As filed with the Securities and Exchange Commission on April 10, 2002. Registration No. 333-67884 ================================================================================ SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 8 to FORM SB-2 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 - AUTOCARBON.COM, INC. (Name of Small Business Issuer in its Charter) Delawar

SB-2/A

As filed with the Securities and Exchange Commission on March 26, 2002. Registration No. 333-67884 ================================================================================ SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 7 to FORM SB-2 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 - AUTOCARBON.COM, INC. (Name of Small Business Issuer in its Charter) Delawar

SB-2/A

As filed with the Securities and Exchange Commission on March 7, 2002. Registration No. 333-67884 ================================================================================ SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 6 to FORM SB-2 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 - AUTOCARBON.COM, INC. (Name of Small Business Issuer in its Charter) Delaware

SB-2/A

As filed with the Securities and Exchange Commission on February 13, 2002. Registration No. 333-67884 ================================================================================ SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 5 to FORM SB-2 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 - AUTOCARBON.COM, INC. (Name of Small Business Issuer in its Charter) Dela

SB-2/A

SB-2/A 1 autocarbonsb2a4120802.txt As filed with the Securities and Exchange Commission on January 7, 2002. Registration No. 333-67884 ================================================================================ SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO.4 to FORM SB-2 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 - AUTOCARBON.COM, INC. (Name of Small Busi

SB-2/A

As filed with the Securities and Exchange Commission on November 29, 2001. Registration No. 333-67884 ================================================================================ SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO.3 to FORM SB-2 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 - AUTOCARBON.COM, INC. (Name of Small Business Issuer in its Charter) Delaw

SB-2/A

As filed with the Securities and Exchange Commission on October 8, 2001. Registration No. 333-67884 ================================================================================ SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO.1 to FORM SB-2 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 - AUTOCARBON.COM, INC. (Name of Small Business Issuer in its Charter) Delawar

SB-2/A

As filed with the Securities and Exchange Commission on October 16, 2001. Registration No. 333-67884 ================================================================================ SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO.2 to FORM SB-2 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 - AUTOCARBON.COM, INC. (Name of Small Business Issuer in its Charter) Delawa

EX-10.1

10.1 (1) Form of Subscription Agreement SUBSCRIPTION AGREEMENT - AUTOCARBON.COM, INC. General. Pursuant to the terms of the offer made by Autocarbon.com, Inc. (the "Company"), a Delaware Corporation, the undersigned hereby tenders this subscription and applies for the purchase of the number of Units, of common stock and warrants, set forth on the signature page of this Agreement, of the Company's

EX-3.2

EX-3.2 4 autocarb101601sb2a3ex32.txt BY-LAWS 3.2 (1) By-laws of Autocarbon.com, Inc. BY-LAWS OF AUTOCARBON.COM, INC. ARTICLE I - OFFICES Section 1. The registered office of the Corporation in the State of Delaware Shall at 2711 Centerville, Road, Suite 400, City of Wilmington, County of New Castle, Delaware, 19808 The registered agent in charge thereof shall be The Company Corporation. Section 2.

SB-2/A

SB-2/A 1 autocarb101501sb2a3.txt As filed with the Securities and Exchange Commission on October 16, 2001. Registration No. 333-67884 ================================================================================ SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO.2 to FORM SB-2 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 - AUTOCARBON.COM, INC. (Name of Small Busin

EX-3.1

3.1 (1) Articles of Incorporation of Autocarbon.com, Inc. CERTIFICATE OF INCORPORATION OF AUTOCARBON.COM, INC. FIRST: The name of the corporation is: AUTOCARBON.COM, INC. SECOND: Its registered office in the State of Delaware is located 2711 Centerville Road, Suite 400, in the City of Wilmington, County of New Castle, 19808. The registered agent in charge thereof is The Company Corporation. THIRD:

EX-10.2

EX-10.2 7 autocarb81501sb2ex102.txt FORM OF COMMON STOCK PURCHASE WARRANT 10.2 (1) Form of Common Stock Purchase Warrant THIS WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THIS WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT MAY NOT BE SOLD, OFFERE

EX-10.3

ROCKET COMPOSITES www.rocketcomposites.com Distribution agreement between: Rocket Composites Ltd. and Autocarbon.com Inc. 18th July 2001 Parties, Autocarbon.com Inc. and Rocket Composites Ltd. Enter into this agreement detailed below for a period of Five Years. No alteration may be made unless by joint written agreement. 1. That Rocket Composites Ltd. gives Autocarbon.com Inc. the license to marke

EX-10.1

EX-10.1 6 autocarb100801sb2a101ex.txt SUBSCRIPTION AGREEMENT 10.1 (1) Form of Subscription Agreement SUBSCRIPTION AGREEMENT - AUTOCARBON.COM, INC. General. Pursuant to the terms of the offer made by Autocarbon.com, Inc. (the "Company"), a Delaware Corporation, the undersigned hereby tenders this subscription and applies for the purchase of the number of Units, of common stock and warrants, set for

EX-3.2

3.2 (1) By-laws of Autocarbon.com, Inc. BY-LAWS OF AUTOCARBON.COM, INC. ARTICLE I - OFFICES Section 1. The registered office of the Corporation in the State of Delaware Shall at 2711 Centerville, Road, Suite 400, City of Wilmington, County of New Castle, Delaware, 19808 The registered agent in charge thereof shall be The Company Corporation. Section 2. The Corporation may also have offices at such

SB-2/A

SB-2/A 1 autocarbsb2a100801.txt As filed with the Securities and Exchange Commission on October 8, 2001. Registration No. 333-67884 ================================================================================ SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO.1 to FORM SB-2 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 - AUTOCARBON.COM, INC. (Name of Small Busines

EX-3.1

3.1 (1) Articles of Incorporation of Autocarbon.com, Inc. CERTIFICATE OF INCORPORATION OF AUTOCARBON.COM, INC. FIRST: The name of the corporation is: AUTOCARBON.COM, INC. SECOND: Its registered office in the State of Delaware is located 2711 Centerville Road, Suite 400, in the City of Wilmington, County of New Castle, 19808. The registered agent in charge thereof is The Company Corporation. THIRD:

EX-10.2

EX-10.2 7 autocarb100801sb2aex102.txt COMMON STOCK PURCHASE WARRANT 10.2 (1) Form of Common Stock Purchase Warrant THIS WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THIS WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT MAY NOT BE SOLD, OFFERED FOR

EX-3.1

EX-3.1 3 autocarb81501sb2ex31.txt ARTICLES OF INCORPORATION 3.1 (1) Articles of Incorporation of Autocarbon.com, Inc. CERTIFICATE OF INCORPORATION OF AUTOCARBON.COM, INC. FIRST: The name of the corporation is: AUTOCARBON.COM, INC. SECOND: Its registered office in the State of Delaware is located 2711 Centerville Road, Suite 400, in the City of Wilmington, County of New Castle, 19808. The registere

SB-2

As filed with the Securities and Exchange Commission on August , 2001. Registration No. ================================================================================ SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SB-2 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 - AUTOCARBON.COM, INC. (Name of Small Business Issuer in its Charter) Delaware XXXX 33-0976805 (State or ot

EX-10.2

10.2 (1) Form of Common Stock Purchase Warrant THIS WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THIS WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTR

EX-3.2

3.2 (1) By-laws of Autocarbon.com, Inc. BY-LAWS OF AUTOCARBON.COM, INC. ARTICLE I - OFFICES Section 1. The registered office of the Corporation in the State of Delaware Shall at 2711 Centerville, Road, Suite 400, City of Wilmington, County of New Castle, Delaware, 19808 The registered agent in charge thereof shall be The Company Corporation. Section 2. The Corporation may also have offices at such

EX-10.1

EX-10.1 6 autocarb81501sb2ex101.txt SUBSCRIPTION AGREEMENT 10.1 (1) Form of Subscription Agreement SUBSCRIPTION AGREEMENT AUTOCARBON.COM, INC. General. Pursuant to the terms of the offer made by Autocarbon.com, Inc. (the "Company"), a Delaware Corporation, the undersigned hereby tenders this subscription and applies for the purchase of the number of Units, of common stock and warrants, set forth o